Clinical Trial Update: Hydroxyurea Optimization Through Precision Study [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating precision optimization of hydroxyurea for sickle cell disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• HYDROXYUREA (Hydroxyurea)

Snippet

Sponsor: Lifespan | Conditions: Sickle Cell Disease, Sickle Cell Anemia | Phase 3 | Status: COMPLETED